The ESMO Position Paper on Biosimilars in Oncology: Enhancing the Provision of Accurate Education and Information

ESMO Open - United Kingdom
doi 10.1136/esmoopen-2017-000245
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Reply to ‘Biosimilars: A Position Paper of the European Society for Medical Oncology, With Particular Reference to Oncology Prescribers’

ESMO Open
Cancer ResearchOncology
2017English

Position Paper of the Italian Association of Medical Oncology on Early Palliative Care in Oncology Practice (Simultaneous Care)

Tumori
MedicineCancer ResearchOncology
2016English

The European Society for Medical Oncology (ESMO)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2012English

The Role of Biosimilars in Value-Based Oncology Care

Cancer Management and Research
Oncology
2018English

Barriers to Oncology Biosimilars Uptake in the United States

Oncologist
Cancer ResearchMedicineOncology
2018English

The Data Revolution in Education. Information Paper No. 39

2017English

Inter-Professional Education and Primary Care: EFPC Position Paper

Primary health care research & development
EnvironmentalPublic HealthCare PlanningOccupational Health
2019English

Editorial: The CAG Position Paper on Pensions

Canadian Journal on Aging
GerontologyGeriatricsHealthHome CareCommunity
1998English

A Call to Action for Expanded Sleep Research in Pediatric Oncology: A Position Paper on Behalf of the International Psycho‐Oncology Society Pediatrics Special Interest Group

Psycho-Oncology
PsychiatryMental HealthOncologyExperimentalCognitive Psychology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy